BioSpace News Archive

The Canadian Neuromuscular Disease Registry and Amylyx Pharmaceuticals (NASDAQ: AMLX) today announced they are partnering on a real‐world evidence generation initiative for Amylyx’ novel investigational therapy AMX0035.

Kriya Therapeutics, Inc. announced today that it has appointed Ma’an Muhsin, M.D., as President and Chief Medical Officer of Kriya Oncology.

Vincerx Pharma, Inc. today announced the publication of a peer-reviewed article.

OPKO Health, Inc. announces that Vifor Fresenius Medical Care Renal Pharma has initiated the commercial launch of RAYALDEE® in Germany, the first launch of RAYALDEE outside the U.S. VFMCRP is OPKO’s commercial partner for RAYALDEE in Europe and selected markets outside the U.S.

InnerScope Hearing Technologies Inc., an emerging and disruptive leader in the Direct-to-Consumer Hearing Technology space, announced that it has successfully negotiated the cancellation of a series of variable price convertible notes, with a total principal amount of $1.1 million held by GS Capital Partners, LLC resulting in a favorable restructuring of its financing agreements.

Pharmaceutical Associates, Inc. (PAI) announces that it has acquired all of the generic and branded US marketing authorizations from Teligent Inc. (Teligent) for an undisclosed amount.

February 3, 2022, collaboration agreement was signed between Allosteric Bioscience, a company founded in 2021 integrating Quantum Computing and Artificial Intelligence with Biomedical sciences to create improved treatments for Aging and Longevity and Polaris Quantum Biotech, a company at the vanguard of Quantum Computing for drug discovery.

Insightec, a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy, announced the treatment of its first US commercial patient for prostate disease at Stanford Health Care.

Kiromic BioPharma, Inc. (NASDAQ: KRBP) (“Kiromic” or the “Company”), today announces changes in management, and in the Company’s Board of Directors.

A leading scientist, known for his studies on the elimination of senescent cells to improve lifespan and healthspan, serves on the scientific advisory board of SRW Laboratories (SRW) to bring more attention to the natural ingredient, fisetin.